SCHEMBL30831012

SCHEMBL30831012

COc1cc(N2CCC3(CCN(C(=O)c4ccc([C@H]5C[C@@H](Nc6cnn(C)c(=O)c6Br)CN(C)C5)cc4)CC3)CC2)cc(F)c1C1CCC(=O)NC1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KAT2B Q92831 7/20 0.44
▸ BRD9 Q9H8M2 4/20 0.44
▸ BRD1 O95696 1/20 0.44
▸ ACHE P22303 1/20 0.44
▸ BRPF1 P55201 1/20 0.44
▸ BPTF Q12830 1/20 0.44
▸ KAT2A Q92830 1/20 0.44
▸ BRD7 Q9NPI1 1/20 0.44
▸ BAZ2B Q9UIF8 1/20 0.44
▸ BRPF3 Q9ULD4 1/20 0.44
▸ PDE5A O76074 2/20 0.32
▸ CD274 Q9NZQ7 1/20 0.32
▸ NR3C1 P04150 1/20 0.31
▸ PGR P06401 1/20 0.31
▸ SLC6A4 P31645 1/20 0.31
▸ KCNH2 Q12809 1/20 0.31
▸ PDE3B Q13370 1/20 0.31
▸ PDE3A Q14432 1/20 0.31
▸ CYP3A4 P08684 2/20 0.31
▸ CYP1A2 P05177 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30831051 0.94 KAT2B (0.45) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830597 0.93 KAT2B (0.44) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830989 0.91 KAT2B (0.45) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830811 0.90 KAT2B (0.48) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30831016 0.90 KAT2B (0.46) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830711 0.89 KAT2B (0.44) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830854 0.89 KAT2B (0.46) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30831061 0.89 KAT2B (0.46) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830603 0.88 KAT2B (0.51) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830728 0.88 KAT2B (0.51) KAT2BBRD9BRD1ACHEBRPF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4581025-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS Auron Therapeutics, Inc. (US) 2025-07-09 — — EP disclosed
WO-2024050078-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS AURON THERAPEUTICS, INC. (US) 2024-03-07 — — WO disclosed
Send feedback